Advertisement

Topics

MCRPC: No OS Increase With Ipilimumab (CME/CE)

00:00 EDT 19 Oct 2016 | MedPageToday

(MedPage Today) -- Study did show, however, increases in PFS and PSA rates

Original Article: MCRPC: No OS Increase With Ipilimumab (CME/CE)

NEXT ARTICLE

More From BioPortfolio on "MCRPC: No OS Increase With Ipilimumab (CME/CE)"

Quick Search
Advertisement